HHS Secretary Robert F. Kennedy Jr. at a House Energy and Commerce Subcommittee hearing (Mariam Zuhaib/AP Images)

June 24, 2025 03:04 PM EDTUpdated 03:42 PM

RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing

Max Bayer

Pharma Reporter

A day after Sen. Bill Cassidy (R-LA) called for a delay to this week’s Advisory Committee on Immunization Practices meeting, HHS chief Robert F. Kennedy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say

Nektar's mid-stage eczema data deliver key win in bid for company turnaround

RFK Jr. pledges to keep the US at the center of the biotech 'revolution'

Former FDA scientist and psychedelics researcher hired as CDER deputy director

Revolution inks up to $2B 'flexible' funding deal to advance RAS inhibitor pipeline

Digital Twins in GMP Manufacturing: Shaping the Future of CPV with Aizon

RFK Jr. says he did not com­mit to up­hold­ing ACIP ros­ter to se­cure Cas­sidy’s back­ing

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

Nek­tar's mid-stage eczema da­ta de­liv­er key win in bid for com­pa­ny turn­around

RFK Jr. pledges to keep the US at the cen­ter of the biotech 'rev­o­lu­tion'

For­mer FDA sci­en­tist and psy­che­delics re­searcher hired as CDER deputy di­rec­tor

Rev­o­lu­tion inks up to $2B 'flex­i­ble' fund­ing deal to ad­vance RAS in­hibitor pipeline

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

RFK Jr. says he did not commit to upholding ACIP roster to secure Cassidy’s backing

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say

Nektar's mid-stage eczema data deliver key win in bid for company turnaround

RFK Jr. pledges to keep the US at the center of the biotech 'revolution'

Former FDA scientist and psychedelics researcher hired as CDER deputy director

Revolution inks up to $2B 'flexible' funding deal to advance RAS inhibitor pipeline

Digital Twins in GMP Manufacturing: Shaping the Future of CPV with Aizon